HERA-OX40L

N/A

Report date: 2024/07/30 14:15:27

Base Information

Drug NameHERA-OX40L
Drug Alias NameHERA-OX40L
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonists
TargetsTumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApogenix Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApogenix Gmbh
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A